Meeting
2015 Gastrointestinal Cancers Symposium
Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival.
Authors
Chan Whiting
Aduro BioTech Inc., Berkeley, CA
Chan Whiting , Eric Lutz , Nitya Nair , Serena Chang , Ed Lemmens , Shih- Yu Chen , Sara Solt , Sandy Ferber , Holden Maecker , Aimee Murphy , Dirk G. Brockstedt , Elizabeth M. Jaffee , Dung T. Le
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Clinical Trial Registration Number
NCT01417000
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 261)
DOI
10.1200/jco.2015.33.3_suppl.261
Abstract #
261
Poster Bd #
A32
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Associations between BMI, morphomics and survival in 528 patients with metastatic pancreatic cancer.
First Author: Valerie Gunchick
Poster
2019 Gastrointestinal Cancers Symposium
CA19-9 decrease and overall survival according to platelet level in patients with metastatic pancreatic cancer.
First Author: Yang Chen
Poster
2016 Gastrointestinal Cancers Symposium
Nutritional status and outcomes of older versus younger patients (pts) with metastatic pancreatic cancer (mPC).
First Author: Namrata Vijayvergia
Poster
2024 ASCO Annual Meeting
Survival associated with chemotherapy and prognostic biomarkers in penile cancer at a reference hospital in the Northeast Brazil from 2000 to 2021.
First Author: Joao Paulo Holanda Soares